Phase 4 Hypertrophic Cardiomyopathy Clinical Trials
5 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–5 of 5 trials
Recruiting
Phase 4
Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy
Hypertrophic Cardiomyopathy (HCM)
Oregon Health and Science University40 enrolled2 locationsNCT07600177
Recruiting
Phase 4
A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)
Symptomatic Obstructive Hypertrophic Cardiomyopathy
Bristol-Myers Squibb50 enrolled31 locationsNCT07004972
Recruiting
Phase 4
Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy
Non-obstructive Hypertrophic Cardiomyopathy
Morten Steen Kvistholm Jensen100 enrolled4 locationsNCT05569382
Recruiting
Phase 4
ENavogliflozin DElivering Alleviation of Ventricular Diastolic Dysfunction in nonObstRuctive Hypertrophic CardioMyopathy
Nonobstructive Hypertrophic Cardiomyopathy
Yonsei University200 enrolled1 locationNCT06580717
Recruiting
Phase 4
Use of SGLT2i in noHCM With HFpEF
Hypertrophic CardiomyopathyHeart Failure With Preserved Ejection Fraction
China National Center for Cardiovascular Diseases94 enrolled1 locationNCT06401343